Tissue Banking Market, by Product (Media and Consumables, and Equipment), by Tissue (Bone, Brain & Spinal Cord, Cornea, Heart Valves, Skin, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2018 - 2026

  • Published On : May 2019 |
  • Pages : 152 Pages |
  • Format : CMI Insight PPT Format CMI Insight PDF Format

Tissue Banking Market – Insights

Tissue banking is the method of harvesting, processing, storage, and distribution of transplantable human tissues. Tissues retrieved from human body are used to repair or replace the diseased or lost tissues of living human body. The common tissues being harvested and used are cornea, bones, fascia, heart valves, skin, cartilage, joints, tendons, and duramater from human cadaver.

The global tissue banking market size was valued at US$ 1.04 billion in 2017 and is expected to witness a CAGR of 10.8% over the forecast period (2018 – 2026).

Global Tissue Banking Market Share (%), By Product 2017

Source: Coherent Market Insights Analysis (2019)

Increasing government initiatives and rising demand for transplantation are expected to drive growth of the tissue banking market

According to University of Texas Southwestern Medical Center 2018 report, about 450,000 Americans underwent tissue transplants to improve or save their lives and nearly 45,000 corneal transplants were done to restore sight. As per the same source, over 300,000 bone grafts were expected to be used in the treatment of degenerative bone diseases, malignancies, and traumatic injuries. Demand for other tissue such as heart valves, and venous and connective grafts also have increased. Heart valves are frequently utilized in pediatric surgeries, even in infants.

According to Ovarian Cancer Canada (OCC), 2017, the OCC Tissue Banking Network collects samples from 800 to 1,000 women with ovarian cancer each year. In 2016, around 1,409 women with gynecological cancers gave tissue, resulting in over 7,000 samples being collected, processed, and banked by the Network.

Tissue Banking Market Restraints

Tissue banking organization is a complex system and needs high technical expertise and skilled personnel for proper functioning in a dedicated facility. Minor errors in the established protocol can lead to loss of expensive tissues, harm to recipients as well as can increase risk of transmission of deadly diseases and tumors. Dearth in tissue availability is also a major factor hindering growth of the tissue banking market. According to Organ Procurement and Transplantation Network (OPTN), in 2016, over 119,000 men, women, and children await lifesaving organ transplants in the U.S., and over 8,000 people die each year due to lack of required organs.

Tissue Banking Market - Regional Insights

On the basis of region, the global tissue banking market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa. Europe tissue banking market is expected to generate significant revenue share during the forecast period, owing to increasing government support. For instance, NHS Blood and Transplant (NHSBT) is a special health authority with responsibility for blood, organ, and tissue donation within the U.K.

Asia Pacific tissue banking market is anticipated to grow at the highest CAGR during the forecast period, owing to initiatives by government to fulfil rising demand and supply gap for tissue banking. In 2017, National Biomaterial Centre (National Tissue Bank), was inaugurated at New Delhi, India, which aims to fill the gap between demand and supply of tissues. The center will also provide quality assurance in the availability of various tissues. According to Health Ministry of India, the national level tissue bank will fulfill the demands of tissue transplantation including activities for procurement, storage, and fulfill distribution of biomaterials.

Global Tissue Banking Market Value (US$ Bn) & Y-o-Y Growth (%)

   

 Source: Coherent Market Insights Analysis (2019)

Tissue Banking Market - Competitive Landscape

Key players operating in the global tissue banking market include AbD Serotec (a Bio-Rad company), AMS Biotechnology Limited, BioLife Solutions, Inc., Beckman Coulter, Inc., BioCision LLC, BioStorage Technologies, Inc., Custom BioGenic Systems, Eppendorf AG, EMD Millipore Corporation, Fisher BioServices, Inc., Genzyme Corporation, Hamilton Company, Merck KGaA, PHC Corporation, and Teva Pharmaceutical Industries Ltd.

Tissue banks recover, process, store, and distribute tissue for transplantation. Research in the field of tissue preservation at low temperature and high clinical success of transplanted tissue led to increase in the use of stored tissue in major burn and trauma patients. Increased demand for allografts resulted in the establishment of in-house tissue banking activity at major burns centers. Tissue banking organization is a complex system and needs high technical expertise and skilled personnel for proper functioning in a dedicated facility.

Market Dynamics

Increasing surgical demands for allografts, demand for bone graft in hip replacements, and femoral head allografts, and increasing incidences of burn patients are the main factors for the growth of the tissue banking market. According to WHO March 2018 report, about 180,000 deaths are caused by burns every year, majority of the cases occur in low and middle income countries. Moreover, aging population is prone to chronic diseases, such as age-related macular degeneration (AMD), glaucoma, and diabetic retinopathy.

Private and public organizations are playing crucial role in fulfilling the gap between demand and supply of tissue. For instance, in 2017, MTF Biologics distributed over 550,000 tissue grafts, which was made possible through the selfless donation by 5,700 individuals. These transplantable tissues helped to heal an estimated 400,000 lives in over 50 countries.

Dearth of highly trained professionals to maintain the tissue banks is the major restraining factor for growth of the tissue banking market. For instance, according to ALZFORUM 2018 report, over the last 50 years, the number of neuropathologists on staff at the Netherlands Brain Bank dropped from 65 to about 15.

Key features of the study:

  • This report provides in-depth analysis of the tissue banking market, market size (US$ Mn), and Compound Annual Growth Rate (CAGR (%)) for the forecast period: 2018 – 2026, considering 2017 as the base year
  • It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by leading players
  • It profiles key players in the global tissue banking market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies
  • Key players covered as a part of this study include AbD Serotec (a Bio-Rad company), AMS Biotechnology Limited, BioLife Solutions, Inc., Beckman Coulter, Inc., BioCision LLC, BioStorage Technologies, Inc., Custom BioGenic Systems, Eppendorf AG, EMD Millipore Corporation, Fisher BioServices, Inc., Genzyme Corporation, Hamilton Company, Merck KGaA, PHC Corporation, and Teva Pharmaceutical Industries Ltd.
  • Insights from this report would allow marketers and management authorities of companies to make informed decision with respect to their future product launch, governmental initiatives, technological upgradation, market expansion, and marketing tactics
  • The global tissue banking market report caters to various stakeholders in this industry, including investors, product manufacturers, distributors, and suppliers for tissue banking market, research and consulting firms, new entrants, and financial analysts

Detailed Segmentation:

  • Global Tissue Banking Market, By Product:
    • Media and Consumables
    • Equipment
      • Cryopreservation Equipment
      • Quality Control Equipment
      • Thawing equipment
      • Others
  • Global Tissue Banking Market, By Tissue Type:
    • Bone
    • Brain & Spinal Cord
    • Cornea
    • Heart Valves
    • Skin
    • Others
  • Global Tissue Banking Market, By Region:
    • North America
      • By Country:
        • U.S.
        • Canada
      • By Product:
        • Media and Consumables
        • Equipment
          • Cryopreservation Equipment
          • Quality Control Equipment
          • Thawing equipment
          • Others
      • By Tissue Type:
        • Bone
        • Brain & Spinal Cord
        • Cornea
        • Heart Valves
        • Skin
        • Others
    • Europe
      • By Country:
        • U.K.
        • Germany
        • Italy
        • Spain
        • France
        • Russia
        • Rest of Europe
      • By Product:
        • Media and Consumables
        • Equipment
          • Cryopreservation Equipment
          • Quality Control Equipment
          • Thawing equipment
          • Others
      • By Tissue Type:
        • Bone
        • Brain & Spinal Cord
        • Cornea
        • Heart Valves
        • Skin
        • Others
    • Asia Pacific
      • By Country:
        • Australia
        • India
        • China
        • Japan
        • ASEAN
        • South Korea
        • Rest of Asia Pacific
      • By Product:
        • Media and Consumables
        • Equipment
          • Cryopreservation Equipment
          • Quality Control Equipment
          • Thawing equipment
          • Others
      • By Tissue Type:
        • Bone
        • Brain & Spinal Cord
        • Cornea
        • Heart Valves
        • Skin
        • Others
    • Latin America
      • By Country:
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
      • By Product:
        • Media and Consumables
        • Equipment
          • Cryopreservation Equipment
          • Quality Control Equipment
          • Thawing equipment
          • Others
      • By Tissue Type:
        • Bone
        • Brain & Spinal Cord
        • Cornea
        • Heart Valves
        • Skin
        • Others
    • Middle East
      • By Country:
        • GCC
        • Israel
        • Rest of Middle East
      • By Product:
        • Media and Consumables
        • Equipment
          • Cryopreservation Equipment
          • Quality Control Equipment
          • Thawing equipment
          • Others
      • By Tissue Type:
        • Bone
        • Brain & Spinal Cord
        • Cornea
        • Heart Valves
        • Skin
        • Others
    • Africa
      • By Country:
        • South Africa
        • Central Africa
        • North Africa
      • By Product:
        • Media and Consumables
        • Equipment
          • Cryopreservation Equipment
          • Quality Control Equipment
          • Thawing equipment
          • Others
      • By Tissue Type:
        • Bone
        • Brain & Spinal Cord
        • Cornea
        • Heart Valves
        • Skin
        • Others
  • Company Profiles
    • AbD Serotec*
      • Company Overview
      • Product Portfolio
      • Financial Performance
      • Recent Highlights
      • Strategies
    • AMS Biotechnology Limited
    • BioLife Solutions, Inc.
    • Beckman Coulter, Inc.
    • BioCision LLC
    • BioStorage Technologies, Inc.
    • Custom BioGenic Systems
    • Eppendorf AG
    • EMD Millipore Corporation
    • Fisher BioServices, Inc.
    • Genzyme Corporation
    • Hamilton Company
    • Merck KGaA
    • PHC Corporation
    • Teva Pharmaceutical Industries Ltd.

“*” marked represents similar segmentation in other categories in the respective section.

 

Table of Contents

  1. Research Objective and Assumption
    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Overview
    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snippet, By Product
      • Market Snippet, By Tissue Type
      • Market Snippet, By Region
    • Coherent Opportunity Map (COM)
  3. Market Dynamics, Regulations, and Trends Analysis
    • Market Dynamics
      • Drivers
      • Restraints
      • Market Opportunities
    • Impact Analysis
    • Market Trends
    • Key Developments
    • Technological Advancements
    • Supply Chain Analysis
    • Regulatory Landscape
    • PEST Analysis
  4. Global Tissue Banking Market, By Product, 2016 – 2026, (US$ Million)
    • Introduction
      • Market Share Analysis, 2018 and 2026 (%)
      • Y-o-Y Growth Analysis, 2017 – 2026
      • Segment Trends
    • Media and Consumables
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
    • Equipment
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
      • Cryopreservation Equipment
      • Quality Control Equipment
      • Thawing Equipment
      • Others
  5. Global Tissue Banking Market, By Tissue Type, 2016 – 2026, (US$ Million)
    • Introduction
      • Market Share Analysis, 2018 and 2026 (%)
      • Y-o-Y Growth Analysis, 2017 – 2026
      • Segment Trends
    • Bone
      •  Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
    • Brain and Spinal Cord
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
    • Cornea
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
    • Heart Valves
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
    • Others
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
  6. Global Tissue Banking Market, By Region, 2016 – 2026, (US$ Million)
    • Introduction
      • Market Share Analysis, By Region, 2018 and 2026 (%)
      • Y-o-Y Growth Analysis, By Region, 2016 – 2026
      • Regional Trends
    • North America
      • Market Size and Forecast, By Product, 2016 – 2026, (US$ Million)
      • Market Size and Forecast, By Tissue Type, 2016 – 2026, (US$ Million)
      • Market Size and Forecast, By Country, 2016 – 2026, (US$ Million)
        • U.S.
        • Canada
    • Europe
      • Market Size and Forecast, By Product, 2016 – 2026, (US$ Million)
      • Market Size and Forecast, By Tissue Type, 2016 – 2026, (US$ Million)
      • Market Size and Forecast, By Country, 2016 – 2026, (US$ Million)
        • U.K.
        • Germany
        • Italy
        • France
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • Market Size and Forecast, By Product, 2016 – 2026, (US$ Million)
      • Market Size and Forecast, By Tissue Type, 2016 – 2026, (US$ Million)
      • Market Size and Forecast, By Country, 2016 – 2026, (US$ Million)
        • China
        • Japan
        • India
        • ASEAN
        • Australia
        • South Korea
        • Rest of Asia Pacific
    • Latin America
      • Market Size and Forecast, By Product, 2016 – 2026, (US$ Million)
      • Market Size and Forecast, By Tissue Type, 2016 – 2026, (US$ Million)
      • Market Size and Forecast, By Country, 2016 – 2026, (US$ Million)
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Africa
      • Market Size and Forecast, By Product, 2016 – 2026, (US$ Million)
      • Market Size and Forecast, By Tissue Type, 2016 – 2026, (US$ Million)
      • Market Size and Forecast, By Country, 2016 – 2026, (US$ Million)
        • Northern Africa
        • Central Africa
        • South Africa
    • Middle East
      • Market Size and Forecast, By Product, 2016 – 2026, (US$ Million)
      • Market Size and Forecast, By Tissue Type, 2016 – 2026, (US$ Million)
      • Market Size and Forecast, By Country, 2016 – 2026, (US$ Million)
        • GCC Countries
        • Israel
        • Rest of Middle East
  7. Competitive Landscape
    • Heat Map Analysis
    • Company Profiles
      • AbD Serotec
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Strategies
      • AMS Biotechnology Limited
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Strategies
      • BioLife Solutions, Inc.
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Strategies
      • Beckman Coulter, Inc.
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Strategies
      • BioCision LLC
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Strategies
      • BioStorage Technologies, Inc.
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Strategies
      • Custom BioGenic Systems
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Strategies
      • Eppendorf AG
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Strategies
      • EMD Millipore Corporation
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Strategies
      • Fisher BioServices, Inc.
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Strategies
      • Genzyme Corporation
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Strategies
      • Hamilton Company
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Strategies
      • Merck KGaA
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Strategies
      • PHC Corporation
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Strategies
      • Teva Pharmaceutical Industries Ltd.
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Strategies
    • Analyst Views
  8. Section
    • References
    • Research Methodology
    • About Us and Sales Contact

*Browse 38 market data tables and 27 figures on "Tissue Banking Market” - Global forecast to 2026”.

Research Methodology

Coherent Market Insights followsa comprehensive research methodology focused on providing the most precise market analysis. The company leverages a data triangulation model which helps company to gauge the market dynamics and provide accurate estimates. Key components of the research methodologies followed for all our market reports include:

  • Primary Research (Trade Surveys and Experts Interviews)
  • Desk Research
  • Proprietor Data Analytics Model

In addition to this, Coherent Market Insights has access to a wide range of the regional and global reputed paid data bases, which helps the company to figure out the regional and global market trends and dynamics. The company analyses the industry from the 360 Degree Perspective i.e. from the Supply Side and Demand Side which enables us to provide granular details of the entire ecosystem for each study. Finally, a Top-Down approach and Bottom-Up approach is followed to arrive at ultimate research findings.


Smiley face

Coherent Market Insights desk research is based on a principle set of research techniques:

  • National level desk research: It Includes research analysis of regional players, regional regulatory bodies, regional trade associations, and regional organization.
  • Multinational level desk research: The research team keeps a track of multinational players, global regulatory bodies, global trade associations, and global organization.

Coherent Market Insights has a large amount of in-house repository of industry database. This is leveraged as a burner for initiating a new research study. Key secondary sources include:

  • Governmental bodies, National and international social welfare institutions, and organizations creating economic policies among others.
  • Trade association, National and international media and trade press.
  • Company Annual reports, SEC filings, Corporate Presentations, press release, news, and specification sheet of manufacturers, system integrators, brick and mortar - distributors and retailers, and third party online commerce players.
  • Scientific journals, and other technical magazines and whitepapers.

Smiley face

Preliminary Data Mining

The raw data is obtained through the secondary findings, in house repositories, and trade surveys. It is then filtered to ensure that the relevant information including industry dynamics, trends, and outlook is retained for further research process.

Data Standardization:

Holistic approach is used to ensure that the granular and uncommon parameters are taken into consideration to ensure accurate results. The information from the paid databases are further combined to the raw data in order to standardize it.

Coherent Statistical model

We arrive at our final research findings through simulation models. Coherent Data Analytics Model is a statistical tool that helps company to forecast market estimates. Few of the parameters considered as a part of the statistical model include:

  • Micro-economic indicators
  • Macro-economic indicators
  • Environmental indicators
  • Socio-political indicators
  • Technology indicators

Data Processing

Once the findings are derived from the statistical model, large volume of data is process to confirm accurate research results. Data analytics and processing tools are adopted to process large chunk of collected informative data. In case, a client customizes the study during the process, the research finding till then are benchmarked, and the process for new research requirement is initiated again.

Data Validation

This is the most crucial stage of the research process. Primary Interviews are conducted to validate the data and analysis. This helps in achieving the following purposes:

  • It provides first-hand information on the market dynamics, outlook, and growth parameters.
  • Industry experts validates the estimates which helps the company to cement the on-going research study.
  • Primary research includes online surveys, face-to face interviews, and telephonic interviews.

The primary research is conducted with the ecosystem players including, but not limited to:

  • Raw Material Suppliers
  • Manufacturers
  • System Integrators
  • Distributors
  • End-users

Choose License Type

"How Can I Help You" ?

Finding it difficult to find the research that would cater to your business demands? Give us a chance to help you. One of our Research Consultants will connect to provide a customized solution.

[email protected]

Key Benefits

  • Custom Research Solution

    Talk to our research consultant to design an exclusive report as per your research needs.

  • Customer Fulfilment

    We aim to fulfil client's research demands with tailored research solutions.

  • Quick Turnaround Time Reports

    We aim to provide research studies in quickest turnaround time and in a much cost effective manner.

  • 360-degree Approach

    We cover each industry from supply and demand side with an aim to provide a most holistic research study.

  • Assured Quality

    We strive to provide most accurate and reliable research findings in our research reports.